Hormonas y Cáncer

Publicaciones

  • Biochimica et Biophysica Acta

    01/06/2017

    Cellular Signalling

    Alpha2-adrenoceptor agonists trigger prolactin signaling in breast cancer cells

    Castillo LF, Rivero EM, Goffin V, Lüthy IA.

  • Current Drug Targets

    30/03/2017

    Current Cancer Drug Targets

    The β2-Adrenergic Agonist Salbutamol Inhibits Migration, Invasion and Metastasis of the Human Breast Cancer MDA-MB-231 Cell Line

    Rivero EM, Piñero CP, Gargiulo L, Entschladen F, Zänker K, Bruzzone A, Lüthy IA.

  • Sub-cellular biochemistry

    01/03/2017

    Journal of Mammary Gland Biology and Neoplasia

    A Novel Effect of β-Adrenergic Receptor on Mammary Branching Morphogenesis and its Possible Implications in Breast Cancer

    Gargiulo L, May M, Rivero EM, Copsel S, Lamb C, Lydon J, Davio C, Lanari C, Lüthy IA, Bruzzone A.

  • 14/12/2016

    Scientific Reports

    Structure-based activity prediction of CYP21A2 stability variants: A survey of available gene variations

    Bruque CD, Delea M, Fernández CS, Orza JV, Taboas M, Buzzalino N, Espeche LD, Solari A, Luccerini V, Alba L, Nadra AD, Dain L.